At the completion of this educational session, learners will:
- Know the major advances and developments in HIV vaccine research.
- Understand key lessons learned from recent clinical trials of preventive HIV vaccines.
- Know future vaccine strategies and product pipeline./li>
- Appreciate challenges in implementing and designing clinical trails in the changing prevention landscape.
Magdalena Sobieszczyk is an Assistant Professor of Clinical Medicine in the Infectious Diseases Division at the Columbia University College of Physicians. Her current research focuses on biomedical HIV prevention strategies, specifically clinical trials of preventive HIV vaccines. Particular interests include assessing combination biomedical prevention strategies such as vaccines together with oral and topical prophylactic antiretrovirals; and evaluating host factors influencing immunologic and virologic course of HIV disease and response to vaccination in study participants. As an investigator in the National Institutes of Health sponsored HIV Vaccine Trials Network (HVTN), a multicenter organization whose mission is to develop an effective preventive HIV vaccine, she has been involved in the development and implementation of several international and national protocols.
To obtain CME credit for this and other PRN programs, please visit the PRN Video Channel
at the Clinical Education Initiative (CEI) web site http://www.ceitraining.org/prn-video/. PRN and the Medical Society of the State of New York (MSSNY) jointly sponsor PRN enduring materials for CME, and provide them at no cost to the AIDS Institute of the New York State Department of Health (NYSDOH) for broadcast through the CEI. We thank the NYSDOH for making our CME programs available to a wider audience, and hope you will also browse the many other educational opportunities offered by the CEI.